Mesirow Institutional Investment Management Inc. reduced its stake in shares of Stericycle, Inc. (NASDAQ:SRCL – Free Report) by 17.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 201,785 shares of the business services provider’s stock after selling 41,908 shares during the period. Mesirow Institutional Investment Management Inc. owned 0.22% of Stericycle worth $11,730,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Wolverine Asset Management LLC acquired a new position in shares of Stericycle in the second quarter worth approximately $3,131,000. Versor Investments LP bought a new position in Stericycle during the second quarter worth $3,250,000. Pentwater Capital Management LP acquired a new position in Stericycle in the second quarter valued at $83,010,000. International Assets Investment Management LLC acquired a new position in Stericycle in the second quarter valued at $45,000. Finally, Innealta Capital LLC bought a new stake in Stericycle during the second quarter valued at $62,000. 98.82% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
SRCL has been the topic of a number of recent analyst reports. Royal Bank of Canada reissued a “sector perform” rating and issued a $62.00 price objective (down from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. Truist Financial boosted their target price on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research note on Tuesday, June 4th. StockNews.com initiated coverage on Stericycle in a research report on Sunday. They set a “hold” rating for the company. Finally, Keefe, Bruyette & Woods boosted their price objective on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $74.00.
Stericycle Price Performance
Shares of NASDAQ SRCL opened at $59.05 on Wednesday. The firm has a market cap of $5.48 billion, a price-to-earnings ratio of -268.41, a price-to-earnings-growth ratio of 3.23 and a beta of 1.11. The stock has a fifty day simple moving average of $58.53 and a two-hundred day simple moving average of $53.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55. Stericycle, Inc. has a 1-year low of $37.78 and a 1-year high of $59.45.
Stericycle (NASDAQ:SRCL – Get Free Report) last announced its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04. The business had revenue of $661.60 million for the quarter, compared to analysts’ expectations of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. Analysts anticipate that Stericycle, Inc. will post 2.29 earnings per share for the current year.
About Stericycle
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Further Reading
- Five stocks we like better than Stericycle
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Stocks to Own if You Are Bearish on The Market
- Why Invest in High-Yield Dividend Stocks?
- Is Wingstop The Perfect Fast Casual Restaurant Model?
- Technology Stocks Explained: Here’s What to Know About Tech
- Why Salesforce Is a Sleeping Giant on the Verge of Waking Up
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.